Table of contents

Association of British Neurologists: Annual Meeting Abstracts 2023

• Screening alzheimer’s disease associated neurodegenerative phenotypes by gene silencing in drosophila melanogaster (28 November, 2023)

  Chilcott Ellie, Cummings Rhiannon, Amadio Leonardo, Sheridan Isabella, Peters Owen
• Blood pressure and amyloid- and tau-PET in a cognitively healthy cohort: the Framingham Heart study (28 November, 2023)

  Mulligan Martin, Yang Qiong, Wang Ruiqi, Beiser Alexa S, Ghosh Saptaparni, Satizabal Clau- dia L, Johnson Keith A, Tracy Russell P, Seshadri Sudha, McGrath Emer R
• Sleep symptomatology in the National prion monitoring cohort (28 November, 2023)

  Porter Marie-Claire, Hyare Harpreet, Rudge Peter, Collinge John, Mead Simon
• Safety and target engagement of tau-targeting ASO BIIB080/ISIS814907 in mild AD: phase 1b trial (28 November, 2023)

  Mummery Catherine, Börjesson-Hanson Anne, Blackburn Daniel, Vijverberg Jolt, de Deyn Peter Paul, Yuang Ellen, Ratti Elena, Bennett Frank, Junge Candice, Lane Roger
• Low-dose interleukin-2 extends survival in ALS: Results of the MIROCALS study (28 November, 2023)

  Leigh Nigel, The MIROCALS Consortium
• Strachan’s syndrome in the UK population (28 November, 2023)

  Kramarz Caroline, S Carr Aisling, Gosal David, Lavin Tim, DM Hadden Robert, Laura Matilde, M Reilly Mary, M Rossor Alexander
• Skin biopsy as a diagnostic tool for hereditary ATTR amyloid neuropathy in the UK (28 November, 2023)

  O’Donnell Luke, Carganillo Roy, Laura Matilde, Gillmore Julian D, Gilbertson Janet A, Rowczenio Dorota, Skorupinska Mariola, Rossor Alexander, Reilly Mary M
• Late-Onset Tay-Sachs (LOTS) disease presenting with a neuromuscular phenotype – a case series (28 November, 2023)

  Fullam Sarah, Togher Zara, Power Alan, McHugh John C, O’Dowd Sean, Ryan Aisling, Lefter Stela, Connolly Sean, Murphy Sinead M, et al
• Whole genome sequencing in practice: focus on the inherited neuropathies (28 November, 2023)

  Record Christopher J, Pipis Menelaos, Skorupinska Mariola, Laura Matilde, Rossor Alexander M, Reilly Mary M
• The role of gut microbiome dysbiosis in epilepsy (28 November, 2023)

  Adenan Mohammad Hijaz, Khalil Mohamed, Delanty Norman, Cavalleri Gianpiero, El-Naggar Hany
• The top ten epilepsy research priorities: a UK priority setting partnership (28 November, 2023)

  Norton Anna, Twohig-Bennett Caoimhe, Smeaton Maxine, Armstrong Jack, Kovac Adam, Cowan Katherine, Epilepsy PSP Steering Group UK, Thomas Rhys
• Acute symptomatic seizures- The 3-year mortality rate (28 November, 2023)

  J Murphy Michael, M Maloney Eimer, J O’Reilly Éilis, J Costello Daniel
• The international consortium for health outcomes measurement recommendations: core outcome measures for epilepsy clinical practice (23 November, 2023)

  Mitchell James W, Sossi Frieda, Miller Isabel, Berg Anne T, ICHOM Working Group Members
• Three and five-year mortality outcomes in a cohort of patients with newly diagnosed epilepsy (23 November, 2023)

  Stack Jessica, Maloney Eimer, Costello Daniel, O Reilly Eilis
• Pseudo-distractibility: a feature of organic painful legs and moving toes syndrome? (23 November, 2023)

  Richard Georgia, Walsh Richard A, Lynch Timothy, Fearon Conor
• Cognitive and behavioural markers improve survival prediction in progressive supranuclear palsy (28 November, 2023)

  Kok Zi Qi, Street Duncan, Rowe James
• A rapid, novel, ultra-sensitive RT-QuIC, for MSA/PD using skin biopsy/serum neu- rofilament light chain (28 November, 2023)

  Olszewska Diana Angelika, Mariinez-Valbuena Ivan, Visanji Naomi P, Sousa Mario, Bhakta Puja, Vasilevskaya Anna, Anastassiadis Chloe, Tartaglia Maria C, Kovacs Gabor C, Lang Anthony E
• Altered Nt-acetylation processes, a new disease-mechanism for autosomal recessive primary familial brain calcifications (28 November, 2023)

  Chelban Viorica, Aksnes Henriette, LaMonica Lauren, Seabra Luis, Maroofian Reza, Horvath Rita, Crow Yanick J, Nicolas Gaël, Arnesen Thomas, Houlden Henry
• Genotype-phenotype correlation in PRKN-associated Parkinson’s disease (28 November, 2023)

  Jayadev Menon Poornima, Sambin Sara, Criniere-Boizet Baptiste, Pastor Pau, Morris Huw, Brock- mann Kathrin, Klein Christine, Brice Alexis, Lesage Suzanne, Corvol Jean-Christophe
• Some clinical features of people with spinal cord only multiple sclerosis (28 November, 2023)

  Auwal Abdusshakur, Day Jacob, Hobart Jeremy, Almasri Omar
• Transcriptomic spatial analysis and multiplex RNAscope of meningeal and perivascular inflammation in multiple sclerosis (28 November, 2023)

  Naughton Michelle, Kee Rachael, McDonnell Gavin V, Howell Owain W, Fitzgerald Denise C
• Immune effector cell-associated neurotoxicity syndrome (ICANS) secondary to CART-cell therapy: experience from a single centre (28 November, 2023)

  Hawken Jonathan, Langford Grace, Castle Daniel, Matthew Laura, Tallantyre Emma, Anand Bawani, Jones Ceri, Willis Mark
• UK MS pregnancy register – A growing database (28 November, 2023)

  Liu Chen, Ford Helen, Hughes Stella, Pearson Owen, Rog David, Murray Katy, Craig Elaine, Middleton Rod, Brex Peter, Dobson Ruth
• Fampridine response in upper and lower limbs in the first year of use in Swansea (28 November, 2023)

  Hrastelj James, Watson Lynne, Ingram Gillian, White Bethan, Hill Marguerite, Pearson Owen
• Hospital healthcare utilisation by people with motor neurone disease: a one-year evaluation (28 November, 2023)

  Yeo Molly, Tanti Matthew, Williams Stefan, Jung Agam
• Guidelines for the diagnosis and treatment of nitrous oxide-induced subacute combined degeneration of the cord (28 November, 2023)

  Paris Alvar, Workman Anna, Walton Joseph, Hayton Tom, Evangelou Nikos, Lilleker James B, Nicholl David, Ayling Ruth M, Noyce Alastair J, et al
• Parallel session 6: Quality, service and training|Thur 11 May, 16:15| 3 Neurology video library: supplementing learning during the pandemic (28 November, 2023)

  Lau Jasmine, Doherty Karen
• A national data dashboard for neurology services (28 November, 2023)

  Wilson Martin, Nirmalananthan Niran, Shribman Sam, Fuller Geraint, Jones Emily, Birch Richard, Morgan Emily, Amin Boskey
• A retrospective cohort study of the 2-week-wait referral pathway vs. neurology same day emergency care (28 November, 2023)

  Rocha Maria Francisca, Sacks Benjamin, Auyeung Ariana, Shirazi Ayala, Alim-Marvasti Ali, Balaratnam Michelle, Chandratheva Arvind, Simister Robert, Haider Salman
• A rare condition unmasked by another rare condition (28 November, 2023)

  Doyle Michael G, Moloney Patrick B, Fenelon Lynda, McQuillan Rory, Widdess-Walsh Peter
• Levelling up or levelling down? (28 November, 2023)

  Allen Claire, Kinton Lucy, Game David
• Clarity second time around (28 November, 2023)

  Whittam Daniel, Matthews Rachael, Shaik Saifuddin
• Out on a limb (28 November, 2023)

  Robinson Rebecca, Kearney Seamus
• Tying it all together! (28 November, 2023)

  Watson-Fargie Taylor, Marshall Victoria, Taylor Rob, Schaefer Andrew, Ng Yi, Gorman Grainne, Farrugia Maria Elena
• A two-centre case series of solid-organ malignancies occurring within a year of Myasthenia Gravis diagnosis (28 November, 2023)

  Ashraghi Mohammad Reza, Baheerathan Aravindhan, Leite M Isabel, Viegas Stuart
• A forgotten cause of cranial neuropathy (28 November, 2023)

  Davda Nikunj
• Cognitive impairment in tuberculous meningitis (28 November, 2023)

  Davis Angharad, Dreyer Anna J, Albertyn Christine, Wasserman Sean, Marais Suzaan, Bateman Kathleen, Solms Mark, Joska John, Wilkinson Robert J, Nightingale Sam
• Development of de novo functional seizures after epilepsy surgery (28 November, 2023)

  Manoj Merlin, Foong Jackie, Baxendale Sallie, De Tisi Jane, McEovy A, Miserrocchi Anna, Duncan John, Yogarajah Mahinda
• A case of new-onset orthostatic tremor post SARS-CoV-2 infection and vaccination (28 November, 2023)

  Tacheva Asya, McElligott Liah, Whelehan Anna, McGovern Eavan
• The carbon footprint of administering disease modifying therapy infusions in multiple sclerosis (28 November, 2023)

  Upcott Matthew, Schroeder Benjamin, Jones Rhiannon, Tallantyre Emma C, Morris Dan S
• A new non-invasive diagnostic method for detection of mitochondrial DNA variants using faecal-derived DNA samples (23 November, 2023)

  Warren Charlotte, Barrow Isabel, Tuppen Helen, Brown Laura, Massarella Clare, Houghton David, Greaves Laura, McFarland Robert, Gorman Gráinne
• An excellent response to corticosteroids and cyclophosphamide in a case of subacute HTLV-1-associated myelopathy (23 November, 2023)

  Hemmati Hosseini Seyed Parsa, Whittam Daniel, Hutchcroft Christopher, Sinha Richa, Taylor Graham, Boardman Jeremy
• Six-month efficacy data for Cenobamate in refractory focal epilepsy – a viable alternative to VNS? (23 November, 2023)

  Aung Pyae, Hayton Tom, Wysota Barbara, Sumangala Salini, Samarasekera Shanika
• Urbach Wiethe Disease: uncovering the role of an ECM1 mutation in BBB dysfunction (23 November, 2023)

  Brennan Declan, Greene Chris, Togher Zara, Hutchinson Siobhan, Doherty Colin, Campbell Matthew
• Anti-epileptic drug loading – an audit and introduction of levetiracetam loading protocol (23 November, 2023)

  Gew Jessie, Black Andrew
• MRI hallmarks of LGI1- and CASPR2-antibody encephalitis (23 November, 2023)

  Kelly Mark J, Grant Eleanor, Murchison Andrew, Sh Uy Christopher E, Binks Sophie, Ramanathan Sundarshini, Sheerin Fintan, Irani Sarosh R
• The (DPP)X factor- patient DPPX antibodies reduce the A-Type potassium current in rat hippocampal neurons (28 November, 2023)

  Mukherjee Trisha, Irani Sarosh, Kullmann Dimitri, Káradóttir Thóra, Crisp Sarah
• EEG in CAR-T Therapy (28 November, 2023)

  Russell Caoimh, Stanila Raluca, Bacon Larry, Doherty Colin, Langan Yvonne
• Incidence of psychogenic non-epileptic seizures in a defined geographical area: a prospective cohort study (28 November, 2023)

  Stack Jessica, Maloney Eimer, Costello Daniel, O Reilly Eilis
• Care and short-term outcomes of patients diagnosed with Benign Epilepsy with Centro-Temporal Spikes (23 November, 2023)

  Steinruecke Moritz, Shetty Jay, Gillespie Conor, Ahmed Najma, Bandyopadhyay Soham, Duklas Dorota, Ghahfarokhi Mahta Haghighat, Henshall David, Khan Medhi, et al
• Factors associated with readmissions among patients with epilepsy in South West London and Surrey (23 November, 2023)

  Tantirige Nayanatara Nadeesha, Shribman Samuel, Parker Andrew, Street Peter, Nirmalananthan Niranjanan, Mula Marco
• Subjective symptom reporting in functional/dissociative seizures and epilepsy: sampling technique and psychological profile effects (23 November, 2023)

  Whitfield Andrew, Wardrope Alistair, Ardern Kerry, Garlovsky Jack, Oto Maria, Reuber Markus
• Oral salbutamol for symptomatic treatment in MuSK Myasthenia Gravis: a single centre experience (23 November, 2023)

  Baheerathan Aravindhan, Dorsey Rachel, Viegas Stuart
• Rituximab use for refractory myasthenia gravis in Wessex (23 November, 2023)

  Carroll Liam Stuart, Kings Jude, Pinto Ashwin, Burke Georgina
• Acute distal neuropathic pain in guillain-barré syndrome (GBS): a multicentre retrospective cohort study (23 November, 2023)

  Chan Laura, O’Brien David, Bryden Graham, Evans Matthew, Ul Huda Syed Shehroz, Keh Ryan, Devine Helen, Carr Aisling, Lavin Tim
• Mycophenolate is better tolerated than azathioprine in myasthenia gravis (23 November, 2023)

  Dodd Katherine, Miller James, Holt James, Ahmed Rohan, Ambrose Philip, Jacob Saiju, Spillane Jennifer, Viegas Stuart, Leite M Isabel, Sussman Jon
• Adult presentation of a rare mitochondrial tRNA Val gene mutation – expanding the phenotype (23 November, 2023)

  Joyce Eimear, Ali Mohib, Richard Georgia, Devadass Abel, Ng Yi Shiau, Martin Fiachra, Whelehan Anna, Lefter Stela
• Potential clinical relevance of AChR antibodies in intravenous immunoglobulin (23 November, 2023)

  Miah Shamim, Nagrodzki Jakub, Compton Laura, Chou Michael, Carr Aisling, Lunn Michael
• Facioscapulohumeral muscular dystrophy with inflammatory myopathy presenting with progressive limb and respiratory muscle weakness (23 November, 2023)

  Mohammed Hamzah, Nihat Akin, Nasir Memoona, Makawita Chulika, Athukoralage Kasun, Deeb Jacquie, Chaudhuri Abhijit
• Spinal MRI findings in UK patients with hereditary ATTR amyloidosis (23 November, 2023)

  O’Donnell Luke, Rossor Alexander, Carganillo Roy, Skorupinska Mariola, Gilbertson Janet A, Rowczenio Dorota, Laura Matilde, Gillmore Julian D, Reilly Mary M
• The diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy: a retrospective audit (23 November, 2023)

  Ryan Marie, Sarwar Zeshan, Killian Owen, Lipsett Olivia, Counihan Timothy, Elamin Marwa, Monaghan Thomas, McGrath Emer, Hennessy Michael
• Epidemiology of the West of Scotland primary mitochondrial disease cohort (28 November, 2023)

  Watson-Fargie Taylor, Farrugia Maria Elena, Ng Yi, Schaefer Andrew, McFarland Robert, Taylor Rob, Turnbull Doug, Gorman Grainne
• The optimal clinical trials platform for progressive multiple sclerosis (OCTOPUS) trial (28 November, 2023)

  The Octopus Trialists
• Patient experiences of being diagnosed and living with myasthenia gravis (28 November, 2023)

  Ashraghi Mohammad Reza, Smith Adrian, Leite M Isabel
• What do doctors think when they think about seizures? (23 November, 2023)

  Khan Maryam, Byrne Susan, McHugh John
• National audit of pathways in epileptic seizure referrals (NAPIER): multicentre audit of first seizure clinics (23 November, 2023)

  Lee Seong Hoon, Gillespie Conor, Bandyopadhyay Soham, Nazari Armin, Ooi Setthasorn Zhi Yang, Park Jay Jaemin, Kinney Michael, Mackay Graham, Myint Phyo Kyaw, Marson Tony
• E-mailing a neuroradiologist in the time of Covid-19 disease (23 November, 2023)

  McCarron Mark, McCullagh Mary
• Towards patient self-care in headache: analysis of a Sláintecare headache service (23 November, 2023)

  McGettigan Jamie, McGuirk Edel, Pilladath Merlin, Bradley Maeve, Hutchinson Siobhán
• Croydon neurology: the impact of neuropsychiatry MDT in reducing service usage frequency in FND patients (23 November, 2023)

  Rane Aditi, Tan Jason, MacDonald Bridget K, Southam Medina, Ali Lia, Nitkunan Arani
• Review of gastrostomy insertions over a 12-month period at a single MND specialist centre (23 November, 2023)

  Rees Abigail, Obrocki Ruth, Waltho Michaela, Howard Robin
• Acute onset vertigo: evaluating the diagnostic accuracy of referring clinicians to neuro-otology specialist service (28 November, 2023)

  Sacks Benjamin, Rocha Maria Francisca, Koohi Nehzat, Kaski Diego
• Developing dashboards for regional neuroscience networks: experience from South West London and Surrey (28 November, 2023)

  Shribman Samuel, Parker Andrew, Street Peter, Murray Sarah, Nirmalananthan Niranjanan
• A case of frontal lobe sagging syndrome (28 November, 2023)

  Ambati Sai, Wilson Claire, Hamandi Khalid
• A systematic review of pharmacological treatments for neuropsychiatric symptoms in Creutzfeldt Jakob disease (23 November, 2023)

  Centola John, Tam Johnny, Kurudzhu Hatice, Hogg Rosie, Millar Mary, Quibell Rachel, Chin Chloe, Bradley Victoria, Pal Suvankar
• Novel inherited prion disease due to E146G mutation has distinctive clinicopathological and CSF biomarker features (23 November, 2023)

  Coysh Thomas, Jaunmuktane Zane, Majbour Nour, Matus Marcelo Barria, Holm-Mercer Leah, Hosszu Laszlo, Brandner Sebastian, Smith Colin, Collinge John, Mead Simon, et al
• The clinical utility of neurodegenerative biomarkers in the cognitive clinic (23 November, 2023)

  Lad Meher, Griffiths Tim
• Real world experience of CSF biomarkers in young onset dementia in Northern Ireland (28 November, 2023)

  McCluskey Gavin, Robinson Rebecca, Duguez Stephanie, McMonagle Paul
• Cerebellar involvement in frontotemporal dementia: the infratentorial imaging signatures of FTD phenotypes (28 November, 2023)

  McKenna Mary Clare, Hutchinson Siobhan, Bede Peter
• Plasma biomarkers predict amyloid- and tau-PET in a cognitively healthy cohort: the Framingham Heart study (28 November, 2023)

  Mulligan Martin, Yang Qiong, Wang Ruiqi, Beiser Alexa S, Ghosh Saptaparni, Satizabal Claudia L, Johnson Keith A, Tracy Russell P, Seshadri Sudha, McGrath Emer R
• Gerstmann-Sträussler-Scheinker syndrome with de novo PRNP P102L mutation in a young adult (28 November, 2023)

  Power Alan, Moore Helena, Mok Tze How, Ryan Aisling
• Screening for dysautonomia complications in guillain-barré syndrome (GBS): a multicentre retrospective cohort study (28 November, 2023)

  Bryden Graham, O’Brien David, Evans Matthew, Shehroz Ul Huda Syed, Chan Laura, Keh Ryan, Devine Helen, Carr Aisling, Lavin Timothy
• OnabotulinumtoxinA for new daily persistent headache and comparison to chronic migraine (28 November, 2023)

  Cheema Sanjay, Lagrata Susie, Ahmed Maha, Kamourieh Salwa, Matharu Manjit
• Immunotherapies and clinical outcomes in peripheral nerve sarcoidosis: a case Series from tertiary neurosarcoidosis clinic (28 November, 2023)

  Englezou Christina, Hofer Monika, Nagaraju Santosh
• Prevalence and clinical features of ‘rarer’ serum-neuronal-cell-surface-antibod- ies in first-episode psychosis: a case-controlled study (28 November, 2023)

  Lim Soon Tjin, Board Callum, Irani Sarosh, Coles Alasdair, Jones Peter, Lennox Belinda
• Defining orthostatic headache in spontaneous intracranial hypotension (28 November, 2023)

  Mehta Dwij, Cheema Sanjay, Glover Sophie, Davagnanam Indran, Qureshi Ayman, Kamourieh Salwa, Matharu Manjit
• Nitrous oxide abuse: neurologists’ experience over a sixteen month period across three Dublin teaching hospitals (28 November, 2023)

  Redmond Aine, Klaus Stephen, Doherty Colin, Kearney Hugh, Ferguson Damien, Reid Valerie, Llamas Yudy, Williams Jennifer, Murphy Sinead M, Smyth Shane, et al
• Determining the risk of spinal pathology progression in NF1 (28 November, 2023)

  Robinson Daniel, Biswas Sayan, Torrie Christopher, MacArthur Joshua, Sial Moska, George Joshi
• Natural history and neuropathology of patients presenting with pure autonomic failure (28 November, 2023)

  Wrigley Sarah, Cullinane Patrick, Jaunmuktane Zane, Revesz Tamas, Warner Tom, De Pablo Fernandez Eduardo
• Disease activity after two courses of cladribine: experience of up to 7.5 years follow up (23 November, 2023)

  Allen-Philbey Kimberley, MacDougall Amy, Adams Ashok, Giovannoni Gavin, Gnanapavan Sharmilee, Marta Monica, Mathews Joela, Turner Ben, Baker David, Schmierer Klaus
• Kinematic assessment detects six month changes in upper limb function in progressive multiple sclerosis (23 November, 2023)

  Fernandes Linford, Hafeez Awais, O Coats Rachel, Mon-Williams Mark, L Ford Helen
• 5-year experience of cyclophosphamide rescue therapy in non-MS CNS inflammation from a national referral centre (23 November, 2023)

  Forcadela Mirasol, Rocchi Chiara, Hamid Shahd, Huda Saif
• Real world annualized relapse rates from UK multiple sclerosis clinics: a retrospective multicentre cohort study (28 November, 2023)

  Hibbert Aimee, Papathanasiou Athanasios, Tallantyre Emma, Harding Katharine, Morgan Matthew, Talaei Maryam, Arun Tarunya, Ingram Gillian, Law Graham, Evangelou Nikos
• Multiple sclerosis genetics in an ancestrally-diverse UK population (28 November, 2023)

  Jacobs Benjamin, Schalk Luisa, Noyce Alastair, Morris Huw, Silber Eli, Giovannoni Gavin, Dobson Ruth, Investigators ADAMS
• Immunoglobulin G subclass profiles of tertiary lymphoid structures in a post-mor- tem multiple sclerosis cohort (28 November, 2023)

  Kee Rachael, Naughton Michelle, Mullan Ger, McDonnell Gavin V, Howell Owain W, Fitzgerald Denise C
• From dictation to database: implementing natural language processing in the UKMS register (28 November, 2023)

  Knowles Sarah, Witts James, Craig Elaine, Nicholas Richard, Middleton Rod
• Steroids decrease diabetic risk in Glutamic Acid Decarboxylase-65 (GAD65) neurological autoimmunity: a retrospective cohort study (28 November, 2023)

  Mulligan MD, Budhram A, Sechi E, Flanagan EP, Dubey D, Zekeridou A, McKeon A, Zalewski NL, Pittock SJ, Pittock ST
• Audit on the application of the 2017 MS McDonald criteria in a tertiary referral centre (28 November, 2023)

  Quigley Suzanne, McKenna Martina, Kearney Hugh
• Work instability in MS: longitudinal findings of a pilot trial for a digital resil- ience-training intervention (28 November, 2023)

  Wicks Charli R, Horton Mike, Pakenham Kenneth, Pavitt Sue, Thompson Laura, Tallantyre Emma, Leary Siobhan, Brownlee Wallace, Pepper George, Ford Helen L
• Evaluating documentation of potential teratogenicity of disease modifying therapies in women with multiple sclerosis (28 November, 2023)

  Hunt Isabelle, Jordan Sinead, Dooley Niamh, Hamilton Tara, Tubridy Niall
• OPTIMISE-MS: real-world safety of disease-modifying therapies for multiple sclerosis (28 November, 2023)

  Jacobs Benjamin, Waddingham Ed, Craner Matt, Miller Aleisha, George Katila, Linighan Ruth, Bianchi Lucia, Matthews Paul, Dobson Ruth, OPTIMISE Investigators
• THC:CBD Nabiximols (Sativex®) for MS spasticity: results from the Northern Ireland MS treatment panel (28 November, 2023)

  Lammey Emma, Mullan Gerry, Macauley Siobhan, Gray Orla, Hughes Stella, Kennedy Fiona, Campbell Jamie, McKee Jon, Turley Niamh, McDonnell Gavin, et al
• Oxidative stress responses – potential peripheral blood biomarkers in MS (23 November, 2023)

  Minton Thomas, Hares Kelly, Kemp Kevin, Redondo Juliana, Scolding Neil, Rice Claire
• Real world experience of Cladribine in an Irish Multiple Sclerosis (MS) centre (23 November, 2023)

  Mulkerrin Grainne, Joseph Bindu, McFarlane Robert, Costelloe Lisa
• Alemtuzumab outcomes in a Northern Ireland MS cohort (23 November, 2023)

  Mullan Gerry, Magill Fiona, Hughes Stella, Kennedy Fiona, Ramsay Stephen, McDonnell Gavin
• Optimising COVID-19 vaccination in people with multiple sclerosis receiving ocrelizumab (28 November, 2023)

  Reid Aisling, Garjani Afagh, Allen Christopher, Tench Christopher, Evangelou Nikos
• Non-elective admissions and readmissions among patients with multiple sclerosis in South West London and Surrey (28 November, 2023)

  Rockett Tay, Shribman Samuel, Parker Andrew, Street Peter, Blain Camilla, Nirmalananthan Niranjanan
• Multiple sclerosis compartmentalised inflammation profiles in a Northern Ireland pre-DMT, post-mortem tissue cohort (28 November, 2023)

  Kee Rachael, Naughton Michelle, Ward Samuel, V McDonnell Gavin, W Howell Owain, C Fitzgerald Denise
• T-cell response and COVID-19 infection following COVID-19 booster vaccinations in pwMS treated with ocrelizumab (28 November, 2023)

  Zaloum Safiya A, Upcott Matthew, Vickaryous Nicola, Scurr Martin J, Anderson Valerie, Loveless Sam, Rios Francesca, George Katila, Tallantyre Emma C, Dobson Ruth
• Referral patterns, first assessments and outcomes in the Irish National deep brain stimulation service (28 November, 2023)

  Abdullah Shaharyar, Ronan Fiona, Garvey Maggie, Austin Neil, Reynolds Elaine, Ruggieri Federica, Lynch Tim, Moran Catherine, Pereira Erlick, Walsh Richard
• Reduced verbal fluency after subthalamic nucleus Parkinsons disease DBS appears linked to processing speed decline (28 November, 2023)

  Austin Neil, Reynolds Elaine, Garvey Maggie, Ronan Fiona, Ruggieri Federica, Shaharyar Abdullah, Pereira Erlick, Moran Catherine, Walsh Richard
• Addressing the gender divide: managing idiopathic Parkinson’s disease in the menopausal and peri-menopausal population (23 November, 2023)

  Bunting Eva, Bryant Jayne, Saha Romi
• RNA-sequencing analysis of hereditary ataxia reveals differential transcriptomic signatures across brain regions and disease pathologies (23 November, 2023)

  Chen Zhongbo, Brenton Jonathan, Gustavsson Emil K, Reynolds Regina H, Rocca Clarissa, McLean Catriona, Tucci Arianna, Jaunmuktane Zane, Houlden Henry, Ryten Mina
• Neurostimulation in cervical dystonia: effects on motor and non-motor symptoms within 5 years follow up (23 November, 2023)

  Khanom Anjum Aarifa, Franceschini Paulo Roberto, Osman-Farah Jibril, Macerollo Antonella
• Urological symptoms in patients with PSP and CBS in a regional specialist centre (28 November, 2023)

  Lyons Shane, O’Shea Noreen, Lynch Tim, Walsh Richard, O’Dowd Sean
• Sex differences in cognitive function in Parkinson’s disease (28 November, 2023)

  Camboe Ellen, Markovic-Obiago Zara, Zirra Alexandra, Haque Tahrina, Dey Kamalesh, Ben-Joseph Aaron, Gallagher David, Badu Caroline, Marshall Charles, Noyce Alastair
• Initiating dopamine agonists rather than levodopa in early Parkinson’s disease does not delay DBS (28 November, 2023)

  Olszewska Diana Angelika, Fasano Alfonso, Munhoz Renato P, Ramirez-Gomez Carolina C, Lang Anthony E
• Fahr’s disease: a patient perspective of presentation and clinical expectations (28 November, 2023)

  Tate Adam, Batla Amit
• Do microglial activity and blood brain barrier permeability predict cerebral small vessel disease progression (28 November, 2023)

  Brown Robin, Walsh Jessica, Tozer Daniel, Markus Hugh
• Prevalence of radiological cerebral small vessel disease in the regional 2-week wait direct-to-scan MDT (28 November, 2023)

  Maskery Mark P, Sen Dwaipayan, Mathur Sachin, Emsley Hedley CA
• Positive visual phenomena in the TIA clinic (28 November, 2023)

  Monaghan Bernadette, Rothwell Peter
• Relationship between reticulated platelet fraction and ex-vivo aspirin responsiveness after transient ischaemic attack/ischaemic stroke (23 November, 2023)

  Offiah Chika, Lim Soon Tjin, Smith Deirdre, Collins Rónán, Ryan Daniel, McCarthy Allan, Tierney Sean, Enright Helen, Cox Dermot, McCabe Dominick
• Incidental white matter lesions on MRI: an audit report from the Luton and Dunstable Hospital (23 November, 2023)

  Perera Chamila, Batla Amit, Latorre Anna, Collorone Sara, Al-MayHani Talal, Cohen Anna, Watts Paul, DeAngelis Floriana
• Cavernoma related epilepsy – a Sheffield cohort (23 November, 2023)

  Rossdeutsch Alexander, Harkness Kirsty, Hanima Imron, Kular Saminderjit, Ushewokunze Shungu, Bhattacharyya Dev, Cahill Varduhi
• Lemierre’s syndrome complicated by cavernous sinus thrombosis, borderzone territory ischaemic stroke and panhypopituitarism (28 November, 2023)

  Watson Neil, Dherwani Vevak, Dewar Simon, Dewdney Charlotte, Lyall Marcus, MacKenzie Scott, Scott Shona, Al-Shahi Salman Rustam, Doubal Fergus
• A sheep in wolf’s clothing (28 November, 2023)

  Chance Charlotte, Street Duncan, Lambert Thomas
• GP access to neurology diagnostics enables timely diagnosis, supports specialist management and improves patient experience (28 November, 2023)

  Coughlan Charles, Rocha Maria, Macarimban Roberto, Gor Mayur, Balaratnam Michelle, Alim-Marvasti Ali, Haider Salman
• Reorganisation of spinal cord circuitry after treatment with fortasyn connect following cervical injury in rats (23 November, 2023)

  Maguire Rebecca, Pallier Patrick, Seira Oscar, Michael-Titus Adina, Tetzlaff Wolfram
• B12 related myeloneuropathy secondary to recreational nitrous oxide use: a new neurological emergency (23 November, 2023)

  McHattie Andrew, Snow Rachel, Patel Kinari, Rizig Mie, Stoica Radu, Jaffer Fatima, Sethi Varun, Everitt Alex, Gabriel Carolyn, Nicholas Richard
• Nitrous oxide admissions in a neuroscience unit 2017–2022- more common than GBS in 2022 (23 November, 2023)

  Nicholl David, Ho Eric, Tom Hayton
• A deep dive into a neurological rarity (28 November, 2023)

  Win May Myat, Kumar Guru, Slattery Catherine, Struzzo Pierluigi, Gallagher David, Hudson Liam, Kyaw Kaung Myat, Alam Adeena, Wai Myat Khant
• Post COVID severe autonomic failure (28 November, 2023)

  Elsheikh Ibrahim Mai, Ingle Gordon
• Autonomic failure is a frequent early prognostic marker of disease progression in variant transthyretin amyloidosis (28 November, 2023)

  Chiaro Giacomo, Thieme Ulrike, Stancanelli Claudia, Koay Shiwen, Vichayanrat Ekawat, Carr Aisling, Reilly Mary, Wechalekar Ashutosh, Whelan Carol
• A case of Harlequin syndrome (28 November, 2023)

  Layegh Mahsa, Osman Chinar
• Disrupted deep sleep and cognitive impairment are associated with multidien heart rate cycles in dementia (28 November, 2023)

  Stephen Auger, Kolanko Magdalena, The CR&T Group, Sharp David
• Fulminant progression in C9ORF72 – A clinicopathological study (28 November, 2023)

  Bradley Maeve, Fullam Sarah, Delaney Siobhan, Bermingham Niamh, Sweeney Brian
• A systematic review of pharmacological treatments for motor symptoms in Creutzfeldt Jakob Disease (CJD) (28 November, 2023)

  Centola John, Tam Johnny, Kurudzhu Hatice, Hogg Rosie, Hughes Terri, Millar Mary, Quibell Rachel, Bradley Victoria, Pal Suvankar
• Neuroimaging signatures of Aβ42 and pTau in brain perfusion SPECT (23 November, 2023)

  Michopoulou Sofia, Prosser Angus, Dickson John, Guy Matthew, Teeling Jessica, Kipps Christopher
• Transient epileptic amnesia with medial temporal lobe swelling on MR imaging: Hughlings Jackson revisited? (23 November, 2023)

  McGinty Ronan, Larner Andrew
• Lecanemab clarity AD: results from a randomised, double-blind phase 3 early Alzheimer’s disease trial (23 November, 2023)

  van Dyck Christopher H, Bateman Randall, Cohen Sharon, McMurray Rob, Sabbagh Marwan, Irizarry Michael, Iwatsubo Takeshi
• The cognitive reaction test (CoRe): a single digit modality test for personal devices (28 November, 2023)

  Lamptey Moesha, Craig Elaine, Nicholas Richard, Middleton Rod
• Persistent cognitive dysfunction in anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis responsive to Bortezomib (28 November, 2023)

  Rees Abigail, Saxena Gauri, Obrocki Ruth, Spillane Jennifer
• Improving the quality of home video to aid the diagnosis of epilepsy (28 November, 2023)

  Browne Hannah, Chohan Gurjit, Davies Sarah, Fawcett Joanna, Manford Mark
• Modelling NMDA receptor activity in focal epilepsy: a resting state study of EEG effective connectivity (23 November, 2023)

  Convertino Laura, Burgess Neil, Walker Matthew, Vivekananda Umesh
• Somatic mutations as a cause of drug-resistant epilepsy including hippocampal sclerosis (23 November, 2023)

  Doyle Michael G, Carton Robert, Kearney Hugh, Lacey Austin, Sweeney Kieron J, O’Brien Donncha F, Henshall David C, Benson Katherine A, Cavalleri Gianpiero, Delanty Norman
• Lingual epilepsy secondary to cortical demyelinating plaque involving the inferior frontal operculum (23 November, 2023)

  Eltahir Musab, Abkur Tarig, Rice Claire
• Arresting new onset refractory status epileptics with early VNS intervention (28 November, 2023)

  Mehboob Sadaf, Mukkadayil Sureshkumar Soorya, Fernandes Linford, Wright Elizabeth, Goodden John, Maguire Melissa
• Towel-induced reflex epilepsy (28 November, 2023)

  Joyce Eimear, Doyle William, Quirke Evan, Munteanu Tudor, Delanty Norman
• Focal 18F-FDG-PET hypometabolism is a predictor of favourable outcome following epilepsy surgery (28 November, 2023)

  Lord James, Joyce Stella, O’Regan Kevin, Costello Daniel
• Non-convulsive status epilepticus or triphasic encephalopathy? (28 November, 2023)

  Matthews Rachael, Markey Keira, Cooper Paul, Cseh Tamas, MacDonagh Ronan, Mohanraj Rajiv
• Antiseizure medication prescribing trends in Northern Ireland: longitudinal analysis from 2010–2020 (28 November, 2023)

  McCullagh Mary, McCluskey Gavin, Kinney Michael
• Does the extent of cortical malformation predict seizure activity? (28 November, 2023)

  Mooney Seán, O’Mahony Olivia, McSweeney Niamh, Sweeney Brian, Costello Daniel
• EMU findings in presumed lesional focal epilepsy (28 November, 2023)

  Mooney Seán, Kinirons Peter, Costello Daniel J
• ‘First Seizure’ clinics by telephone can be safe and effective (28 November, 2023)

  Hunter Annemarie, McConville John, Fulton Ailsa, Gray Orla, Kerr Andrew, Barr Stephen, Patterson Victor
• Cenobamate for refractory epilepsy – Cardiff’s experience (28 November, 2023)

  Schroeder BE, Esposito Michelle, Bruce Lauren, Smith PEM, Hamandi Khalid
• Social deprivation and failure to attend first seizure education sessions (28 November, 2023)

  Landais Raphaelle, Glenton Joanne, Clarke Gemma, Dimmock Louise, Sparke Lisa, Akay Ela, Ellawela Shan, Thomas Rhys
• Status epilepticus recorded on stereo-EEG: insights into seizure onset, propagation, and termination (28 November, 2023)

  Wall Jasmine, Alarcon Gonzalo, Trujillo-Barreto Nelson, Kargwell Haga, Mohanraj Rajiv
• She’s the One… who wanted to be 16 again (28 November, 2023)

  Cabreira Verónica, Stone Jon
• Clinical characteristics of patients with refractory non-epileptic seizures (28 November, 2023)

  Fullam Sarah, Costello Daniel J
• Mastering the art: approaches to diagnosis and management of functional neurological disorders in Irish neurology (28 November, 2023)

  Killian Owen, Elamin Marwa, Ryan Marie, Counihan Timothy, Hennessy Michael, Monaghan Thomas, McGrath Emer
• Atogepant efficacy in people with chronic migraine with and without acute medication overuse: PROGRESS trial (28 November, 2023)

  Goadsby Peter, Friedman Deborah, Holle-Lee Dagny, Demarquay Genevieve, Ashina Sait, Yun Yu Sung, Dabruzzo Brett, Guo Hua, Schwefel Brittany, Trugman Joel
• Chronic migraine epidemiology and outcomes – International (CaMEO-I) study: findings for diagnosis rates and care (28 November, 2023)

  Buse Dawn, Leroux Elizabeth, Lanteri-Minet Michel, Sakai Fumihiko, Matharu Manjit, Katsarava Zaza, Reed Michael, Fanning Kristina, Lipton Richard, et al
• Effect of atogepant on patient reported outcomes in the preventive treatment of chronic migraine (28 November, 2023)

  Lipton Richard, Pozo-Rosich Patricia, Dodick David, Friedman Deborah, Ailani Jessica, Smith Jonathan, Stokes Jonathan, Schwefel Brittany, Gandhi Pranav
• Real-world reductions in monthly migraine days and healthcare resource utilisation in UK patients using fremanezumab (28 November, 2023)

  Afridi Shazia, Totev Todor, Krasenbaum Lynda, Terasawa Emi, Akcicek Hasan, Dhiraj Dalbir, Sun Rochelle, Yilma Binyam, Driessen Maurice
• A retrospective single-centre real-world analysis of efficacy & safety of Fremanezumab in refractory migraine at UHNM (23 November, 2023)

  Moe Zaw, Ho Eric, Gowda Ashwin, Poole Carrie, Winstanley Claire, Foddy Lisa, Kioulachidis Konstantinos, Davies Brendan
• Croydon neurology: not another patient with headache (23 November, 2023)

  Guldemond Anja, Vidanagamage Anomali, Nitkunan Arani
• Optimising the management of headache patients attending emergency department to avoid hospital admission (23 November, 2023)

  Offiah Chika, Moran Sharon, Bogdanova-Mihaylova Petya
• Analysis of neurology referrals for sudden onset headache relative to positive diagnosis of subarachnoid haemorrhage (23 November, 2023)

  Vlachou Aikaterini, Brennan Amy, Jamali Rabee, Quinn Thomas, Randall Marc
• Post COVID cerebellitis (23 November, 2023)

  Ali Hamza, Khan Aamir
• SARS-CoV-2 omicron variant-associated acute haemorrhagic leukoencephalitis without respiratory impairment (23 November, 2023)

  Anwyll Natalie, Fawcett Joanna, Chohan Gurjit
• Under the ecuadorian spider’s web, a stroke (23 November, 2023)

  Ceronie Bryan, Abeywickrema Movin, Nabarro Laura, Godbole Gauri, O’Hara Geraldine, Manji Hadi
• Acute necrotizing encephalopathy in an adult with influenza A (23 November, 2023)

  Day Jacob Oliver, Noushad Muhammed Ameen, McGavin Lucy, Lashley Daniel
• Herpes simplex encephalitis presenting with an anterior temporal lobe haematoma (23 November, 2023)

  Eltahir Musab, Erdogan Hulya, Abkur Tarig, Ramadurai Gopinath
• A case of treatment naive Hepatitis C presenting with longitudinally extensive transverse myelitis (23 November, 2023)

  Harikrishnan Sreedharan, Rahman Mohammed, Farooki Roopa, Singh Abhishek, Changaradil Deepthi, Manokaran Ponnambalam, Kyaw Kaung, Broad Rebecca
• A nervous bite (23 November, 2023)

  Mcloughlin Benjamin, Rice-Wilson Daniel, Carveth-Johnson Tembe, Sesath Randiva, Chatterjee Fiona, Harrington David, Marshall Charles, Shah Apeksha
• AIDS-related CMV neurologic disease (28 November, 2023)

  Omar Dashne
• A rare case report of Enterovirus (EV) encephalitis following rituximab therapy for rheumatoid arthritis (28 November, 2023)

  Subha Sanjai, Elbadri Maha, Hayton Thomas
• JEWELFISH: 24-month safety and pharmacodynamic data in non-treatment- naïve patients with spinal muscular atrophy (SMA) (28 November, 2023)

  Scoto Mariacristina, Bruno Claudio, Fischer Dirk, Kirschner Janbernd, Mercuri Eugenio, Carruthers Imogen, Gerber Marianne, Kletzl Heidemarie, Gidaro Teresa, Muntoni Francesco
• Safety update: risdiplam clinical trial programme for spinal muscular atrophy (SMA) (28 November, 2023)

  Servais Laurent, Baranello Giovanni, Chiriboga Claudia, Darras Basil, Gerber Marianne, Gorni Ksenija, Jaber Birgit, McIver Tammy, Scalco Renata, Mercuri Eugenio
• SUNFISH: 4-year efficacy and safety data of risdiplam in types 2 and 3 SMA (28 November, 2023)

  Servais Laurent, Day John, Mazzone Elena, Nascimento Andres, Oskoui Maryam, Baranello Giovanni, Gerber Marianne, Martin Carmen, Yeung Wai Yin, Mercuri Eugenio
• A case of flail limb amyotrophic lateral sclerosis with significant sensory loss on neurophysiological studies (28 November, 2023)

  Sacks Benjamin, Rocha Maria Francisca, Balaratnam Michelle
• Beating Brexit; one year outcomes following STN DBS in Parkinson’s in a cross-channel collaboration (28 November, 2023)

  Abdullah Shaharyar, Ronan Fiona, Garvey Maggie, Austin Neil, Reynolds Elaine, Ruggieri Federica, Fearon Conor, Lynch Tim, Pereira Erlick, Walsh Richard
• Sequencing device-aided therapy in Parkinson’s disease – Comparing apomorphine with DBS in patients switching treatment (28 November, 2023)

  Abdullah Shaharyar, Ronan Fiona, Garvey Maggie, Austin Neil, Reynolds Elaine, Ruggieri Federica, Lynch Tim, Moran Catherine, Pereira Erlick, Walsh Richard
• Effectiveness of early intrathecal baclofen therapy for severe generalised dystonia in hypoxic brain injury (28 November, 2023)

  Ali Muna, Levins Kirk, McElligott Jacinta
• A great masquerader (28 November, 2023)

  Bansal Dhruv, McKinley John
• Young onset atypical parkinsonism, personality change and cognitive decline (28 November, 2023)

  Binti Mohamad Malihah, Kearney Seamus
• Developing a protocol to evaluate patient and care partner engagement in the EJS ACT-PD initiative (28 November, 2023)

  Carroll Marie Louise Zeissler, Chapman Rebecca, Collins Sally, Ellis-Doyle Romy, Gonzalez-Robles Cristina, Mills Georgia, Foltynie Thomas, Carroll Camille, McFarthing Kevin, on behalf of the EJS ACT- PD initiative
• Mapping UK Parkinson’s disease clinical research capability for the EJS ACT-PD initiative (28 November, 2023)

  Chapman Rebecca, Collins Sally, Ellis-Doyle Romy, Gonzalez-Robles Cristina, Mills Georgia, Zeissler Marie-Louise, Foltynie Thomas, Carroll Camille, Mullin Stephen, on behalf of the EJS ACT-PD Consor- tium
• Towards a multi-arm, multi-stage trial for disease modification in Parkinson’s: The EJS ACT-PD initiative (28 November, 2023)

  Mills Georgia, Chapman Rebecca, Collins Sally, Ellis-Doyle Romy, Gonzalez-Robles Cristina, Zeissler Marie-Louise, Carroll Camille, Foltynie Thomas, on behalf of the EJS ACT-PD Consortium
• Rapid good ON-time-onset and motor symptom improvement in aPD patients treated with subcutaneous foslevodopa/foscarbidopa (28 November, 2023)

  Pahwa Rajesh, Soileau Michael, Standaert David, Fung Victor, Kimber Thomas, Malaty Irene, Merola Aristide, Epstein Andrew, Aldred Jason, et al
• New onset cervical dystonia in pregnancy (23 November, 2023)

  Donlon Eoghan, Moloney Pat, Frier Darragh, McFarlane Robert, Smyth Shane, Molloy Fiona, Walsh Richard, Lynch Tim, McGovern Eavan
• SPG7: a case presented predominantly with parkinsonism and dystonia (23 November, 2023)

  Eissa Alyaa, Warren Naomi
• A wandering vertical route (23 November, 2023)

  Eltahir Musab, Abkur Tarig
• Longitudinal follow up of the Huntington’s Disease Young Adult Study (HD-YAS 2.0) (28 November, 2023)

  Farag Mena, Murphy Michael, Fayer Kate, Hobbs Nichola, Scahill Rachael, Tabrizi Sarah, HD-YAS Investigators
• Prevalence of primary tauopathies; a clinically-defined study in Leinster: study design and initial data (28 November, 2023)

  Lyons Shane, O’Shea Noreen, Lynch Tim, Walsh Richard, O’Dowd Sean
• Sex differences in motor function in Parkinson’s disease in a diverse East London population (28 November, 2023)

  Markovic-Obiago Zara, Camboe Ellen, Zirra Alexandra, Haque Tahrina, Dey Kamalesh, Ben-Joseph Aaron, Gallagher David, Badu Caroline, Simonet Cristina, Noyce Alastair
• Sex differences in non-motor symptoms in Parkinson’s disease in a diverse East London population (28 November, 2023)

  Markovic-Obiago Zara, Camboe Ellen, Zirra Alexandra, Haque Tahrina, Dey Kamalesh, Ben-Joseph Aaron, Gallagher David, Badu Caroline, Simonet Cristina, Noyce Alastair
• Exploring the early neuropathology of Huntington’s disease using 7T MRI and MEG in HD-YAS 2.0 (28 November, 2023)

  Murphy Michael, Farag Mena, Nakajima Mitsuko, Fayer Kate, McColgan Peter, Z Hobbs Nichola, Rees Geraint, Scahill Rachael, Tabrizi Sarah, HD-YAS Investigators
• Improving Huntington’s disease care: insights from admissions at a tertiary neurology centre 2019–2022 (28 November, 2023)

  Quinn Thomas, Cosgrove Jeremy
• Gait and balance outcomes in Parkinson’s disease patients post subthalamic nucleus deep brain stimulation(STN-DBS) (28 November, 2023)

  Reynolds Elaine, Belton Anne, Bollard Eva, Ronan Fiona, Ruggieri Federica, Garvey Maggie, Austin Neil, Pereira Erlick, Moran Catherine, Walsh Richard
• Factors associated with readmissions among patients with Parkinson’s disease in South-West London and Surrey (23 November, 2023)

  Yan Angela, Shribman Samuel, Parker Andrew, Street Peter, Leake Alison, Paviour Dominic, Nirmalananathan Niranjanan
• Poor response to anti-CD 20 treatment in a relapsing-remitting demyelination patient with Baló-like lesions (23 November, 2023)

  Abdelaziz Ammar, Abdel-Aziz Khaled
• Patients’ experience of the multiple sclerosis diagnostic pathway (23 November, 2023)

  Allen Christopher, Liu Brandon, Bale Clare, Tallantyre Emma, Schmierer Klaus, Partlett Christopher, das Nair Roshan, Evangelou Nikos
• Effect of longer-term ofatumumab treatment on disability progression and brain volume change (23 November, 2023)

  Cohen Jeffrey, Hauser Stephen, Fox Edward, Zielman Ronald, Azmon Amin, Xi Jing, Cox Gina Mavrikis, Robertson Derrick, Wiendl Heinz, Kappos Ludwig
• Efficacy of early ofatumumab versus late-teriflunomide switch: subgroup analysis by prior DMT exposure and age (23 November, 2023)

  Cohen Jeffrey, Gold Ralf, de Seze Jerome, Robertson Derrick, Wiendl Heinz, Wray Sibyl, Sacca Francesco, Zielman Ronald, Azmon Amin, Kappos Ludwig
• Pregnancy outcomes in patients with MS following exposure to ofatumumab: Updated results (Novartis safety database) (23 November, 2023)

  Bove Riley, Amato Maria Pia, Dobson Ruth, Krysko Kristen, Stoll Sharon, Vukusic Sandra, Yamout Bassem, Gummuluri Krishna Swetha, Jehl Valentine, Hellwig Kerstin
• Diroximel fumarate pregnancy outcomes in EVOLVE-MS-1 and prospective MS pregnancy exposure registry study design (28 November, 2023)

  Houtchens Maria, Wundes Annette, Osborne Benjamin, Božin Ivan, Chen Hailu, Davies Heather, Levin Seth, Lin Xiaochen, Scaramozza Matthew, Hellwig Kerstin
• Long-term effectiveness of natalizumab for RRMS: UK and global 2022 results from TYSABRI observational program (28 November, 2023)

  Nicholas Richard, Harrower Timothy, Sun Zhaonan, Davies Heather
• COVID-19 antibody response by vaccine type and lymphocyte count in RMS patients on ponesimod (28 November, 2023)

  Dhaliwal Raji, Wong J, Hertoghs N, Lemle A, Linscheid P, Raghavan N, Singh A, Sidorenko T
• Wegener’s vagueness: midfacial granulomatosis with polyangiitis, or cocaine usage? (28 November, 2023)

  Dias James, Doshi Anisha, Sanverdi Eser, Abedo I, Sumasinghe S, Gordon Patrick, Kumar Guru, Ellis Cathy
• Disease activity after short-term interruption of ponesimod versus teriflunomide in relapsing multiple sclerosis patients (28 November, 2023)

  Duminica Gabriela-Loredana, Lublin Fred, Ait-Tihyaty Maria, Keenan Alexander, Gandhi Kavita, Turkoz Ibrahim, Sidorenko Tatiana, Wong Janice, Kappos Ludwig
• Longitudinal clinical and MRI-outcomes in relapsing multiple sclerosis patients after short-term ponesimod treatment-interruption and re-initiation (28 November, 2023)

  Duminica Gabriela-Loredana, Kappos Ludwig, Keenan Alexander, Gandhi Kavita, Turkoz Ibrahim, Ait-Tihyaty Maria, Wong Janice, Sidorenko Tatiana, Lublin Fred
• Cephalgic syndromes following optic neuritis: a case series (28 November, 2023)

  Forcadela Mirasol, Rocchi Chiara, Hamid Shahd, Huda Saif
• Modifiable risk factors for multiple sclerosis are consistent across ethnic backgrounds (28 November, 2023)

  Jacobs Benjamin, Tank Pooja, Bestwick Jonathan, Noyce Alastair, Marshall Charles, Mathur Rohini, Giovannoni Gavin, Dobson Ruth
• OCTOPUS: efficient recruitment for an efficient trial platform (28 November, 2023)

  Middleton Rod, Craig Elaine, Braisher Marie, Tallantyre Emma, Scott Susan, Brownlee Chris, Pugh Cheryl, Mangion-Apap Sean, Wade Charles, Chataway Jeremy
• UTIs and chest infection are associated with higher disability in algorithmically identified multiple sclerosis (28 November, 2023)

  Witts James, Middleton Rod, Nicholas Richard
• Natalizumab treatment satisfaction in the TONiC-MS study: latest results (28 November, 2023)

  Mills Roger J, James Bethan, Satkeviciute Ieva, Davies Heather, Langdon Dawn, Ando Hikari, Young Carolyn
• A panel for higher efficacy disease modifying therapies: observations on the first 1000 case discussions (28 November, 2023)

  Mullan Gerry, Flynn Peter, Campbell Jamie, Gray Orla, Turley Niamh, Kennedy Fiona, Ramsay Stephen, Kee Rachael, Hughes Stella, McDonnell Gavin
• Is there equity of access to highly effective MS disease modifying therapies in N Ireland? (28 November, 2023)

  Mullan Gerry, Campbell Jamie, Gray Orla, Turley Niamh, Kennedy Fiona, McKee John, Ramsay Stephen, Hughes Stella, McDonnell Gavin, et al
• Final analysis of pregnancy outcomes following exposure to dimethyl fumarate in a prospective international registry (28 November, 2023)

  Hellwig Kerstin, Rog David, McGuigan Christopher, Houtchens Maria, Bruen Denise, Mokliatchouk Oksana, Branco Filipe, Levin Seth, Lin Xiaochen
• 2 cases of idiopathic immune reconstitution-related demyelination following rituximab treatment (23 November, 2023)

  Skelly Donal, Jakabek David, Buckley Camilla, Pretorius Pieter, Irani Sarosh, Leite Isabel
• Patients treated with ponesimod demonstrate reductions in serum neurofilament light chain levels (23 November, 2023)

  Talbot Jordan, Kuhle Jens, Ait-Tihyaty Maria, Singh Amita, Turkoz Ibrahim, Saad Ziad, Burcklen Michel, Wong Janice, Sidorenko Tatiana, Kappos Ludwig
• Preservation of myelin in patients with relapsing multiple sclerosis treated with ponesimod compared to teriflunomide (23 November, 2023)

  Talbot Jordan, Datta Ritobrata, Turkoz Ibrahim, Wuerfel Jens, DiBernardo Allitia, Ait-Tihyaty Maria, Saad Ziad, Kolb Hartmuth
• Measurement variability in dynamic contrast-enhanced MRI of the brain (28 November, 2023)

  Varatharaj Aravinthan, Jacob Carmen, Darekar Angela, Gawne-Cain Mary, Cramer Stig, Larsson Henrik, Galea Ian
• Squats and a spag bol: a recipe for disaster (28 November, 2023)

  Baheerathan Aravindhan, Hamilton-Shield Antonia, Williams Stephanie, Viegas Stuart, Sethi Varun
• HNRNPA2B1 myopathy presenting in a family with an adult-onset oculopharyn- geal muscular dystrophy-like phenotype (28 November, 2023)

  Carroll Liam Stuart, Hammans Simon Richard
• A puzzling case of life threatening non-traumatic rhabdomyolysis (28 November, 2023)

  Chapman Miles, Broad Rebecca, Mohamed Hind, Mahfouz Nour, Kyaw Kaung, Harikrishnan Sreedharan
• GNE myopathy: genotypic and phenotypic variability (23 November, 2023)

  Dudley Alex, Kennelly Laura, Connolly Sean, Mc Guigan Christopher
• Myopathy and endocrinopathy – expanding the phenotype of SIN3A-related disorder/Witteveen-Kolk syndrome (23 November, 2023)

  Field Robert, McHugh John, Gibney James, Murphy Sinéad
• VCP multisystem proteinopathy: a ubiquitous culprit of neuronal degeneration (23 November, 2023)

  Fullam Sarah, Power Alan, Stack Jessica, Bermingham Niamh, McNamara Brian, Merwick Aine
• An unusual case of necrotizing myositis in a 53 year old female (28 November, 2023)

  Hamilton Tara, Tuohy Orla
• A case of X-linked myotubular myopathy mimicking hereditary spastic paraparesis (28 November, 2023)

  Hunt Isabelle, Merwick Aine
• Investing to save GM: evaluation of unplanned hospital admissions of neuromuscular patients in greater Manchester (28 November, 2023)

  Almadhi Marwah Ali, Kelly Phillip, Atherton Claire, Rickson Jey, Rutherford Anna, Cseh Tamas, Roberts Mark, Lilleker James
• Healthcare resource utilisation and costs of myasthenia gravis in secondary care and variance by geography (28 November, 2023)

  van Enkhuizen Jordy, Binns Jean, Betts April, Le Treust Luca, Jacob Saiju
• ‘A diagnostic test was completed’ – a case of intravascular large B cell lymphoma (28 November, 2023)

  Robinson Rebecca, Herron Brian, Moore Michelle, Lawless Sarah, Harley Martin, Kennedy Fiona
• Intravascular large B-cell lymphoma mimicking primary angiitis of the central nervous system (28 November, 2023)

  Tacheva Asya, Chalissery Albi, Beausang Alan, McGovern Eavan, Costelloe Lisa, Guilfoyle Patricia, Sheehan Orla, Dolan Eamon
• Bing-Neel syndrome: a rare complication of a rare haematological malignancy to remember (28 November, 2023)

  Thatparan Thanusya, Hobson Esther, Newby Rachel, Wardrope Alistair, Ismail Azza, Bhattacharyya Dev, Romanowski Charles, Kelsey Philippa, Sharrack Basil, Cahill Varduhi
• Iron deficiency as a cause of vision-threatening intracranial hypertension (28 November, 2023)

  Day Jacob Oliver, Abdelgadir Eiman, Gajdosova Eva
• To drain or not to drain? Optic neuritis with concurrent paranasal sinusitis (28 November, 2023)

  Dias James, Doshi Anisha, Sanverdi Eser, Kumar Guru
• Rapidly deteriorating vision secondary to venous sinus thrombosis in pregnancy (28 November, 2023)

  Shive Gowda Ashwin, Simoni Michela, Tzerakis Nick, Gopal Gomathy, Sutton David, Mollan Susan
• Eyes don’t lie – opsoclonus ataxia syndrome as a first presentation of ovarian teratoma (28 November, 2023)

  Sureshkumar Soorya, Mehboob Sadaf, Yeo Molly, Yasiry Zeid, Williams Stefan
• Spastic Paraplegia 7 (SPG7) related disease: a neurological disorder more common than you may think (28 November, 2023)

  Carroll Liam Stuart, Hammans Simon Richard
• Dual pathology exists – a case of SPG 31 and myelopathy (28 November, 2023)

  Layegh Mahsa, Osman Chinar
• Adult onset neurodevelopmental disorder with regression, abnormal movement, loss of speech and seizures (NEDAMSS) (28 November, 2023)

  McElligott Liah, Lockhart Andrew, Mulrooney Mark, Fulcher Tim, McGovern Eavan, Costelloe Lisa
• Metabolic stress due to metformin as a possible precipitating factor in MELAS: a case report (28 November, 2023)

  Zhang Xin, Mukherjee Trisha, Ingle Gordon
• Mitophagy is impaired in MELAS (28 November, 2023)

  Mukherjee Trisha, Cleeter Michael, Gegg Matthew, Schapira Anthony
• Post-transcriptional microRNA repression of the dosage-sensitive PMP22 gene in severe demyelinating Charcot-Marie-Tooth disease (28 November, 2023)

  Pipis Menelaos, Won Seongsik, Poh Roy, Polke James, Skorupinska Mariola, Blake Julian, Rossor Alexander, Laura Matilde, Svaren John, Reilly Mary
• Proteogenomic identification of mis-splicing biomarkers in ALS/FTD (28 November, 2023)

  Seddighi Sahba, Qi Yue Andy, Brown Anna-Leigh, Wilkins Oscar, Bereda Colleen, Belair Cedric, Zhang Yongjie, Petrucelli Leonard, Fratta Pietro, Ward Michael
• Assessment of FTLD genes and C9orf72 repeat length in atypical Parkinsonism (28 November, 2023)

  Vaughan David, Real Raquel, Jabbari Edwin, Wu Lesley, Jaunmuktane Zane, Warner Tom, Tucci Arianna, Rowe James, Rohrer Jonathon, Morris Huw
• A two-centre case series of haematological malignancies occurring in patients with myasthenia gravis (28 November, 2023)

  Baheerathan Aravindhan, Ashraghi Mohammad, Quirke Mary, Leite Isabel, Viegas Stuart
• Treatment challenge: anti-MDA5 myopathy and vasculitic neuropathy case (28 November, 2023)

  Elmashharawi Tareq, Craig John, McConville John
• Subgroup outcomes from RAISE: a randomised, Phase 3 trial of zilucoplan in generalised myasthenia gravis (28 November, 2023)

  Hewamadduma Channa, Bresch Saskia, Juntas-Morales Raul, Leite Isabel, Maniaol Angelina, Zajda Malgorzata, Boroojerdi Babak, Duda Petra, de la Borderie Guillemette, Howard James
• RAISE-XT: interim analysis of an open-label extension study of zilucoplan in patients with myasthenia gravis (28 November, 2023)

  Leite Maria Isabel, Genge Angela, Mantegazza Renato, Utsugisawa Kimiaki, Duda Petra, Boroojerdi Babak, Vanderkelen Mark, de la Borderie Guillemette, Howard James
• Rozanolixizumab efficacy in generalised myasthenia gravis: Subgroup analyses from the randomised, phase 3, MycarinG study (28 November, 2023)

  Moxey Jo, Drużdż Artur, Grosskreutz Julian, Mantegazza Renato, Utsugisawa Kimiaki, Vissing John, Lejdstrom Raphaëlle Beau, Boehnlein Marion, Grimson Fiona, Bril Vera
• Zonisamide-associated renal tubular acidosis resulting in hypokalaemic myopathy (28 November, 2023)

  O’Connor Antoinette, Cormican Sarah, Ward Frank, McEvoy Catriona, Egan Allyson, Smyth Shane, Alexander Michael, Murphy Sinead
• In silico predictive tools versus invivo functional characterisation of CLCN1 genetic variants in muscle channelopathies (28 November, 2023)

  Vivekanandam Vinojini, Ellmers Rebecca, Jayaseelan Dipa, Houlden Henry, Männikkö Roope, Hann Michael
• Developing a data-driven framework to inform drug selection for motor neuron disease clinical trials (23 November, 2023)

  Wong Charis, Cardinali Alessandra, Selvaraj Bhuvaneish, Dakin Rachel, Pal Suvankar, Carragher Neil, Chandran Siddharthan, Macleod Malcolm
• Classical superficial siderosis in Marfan’s syndrome (23 November, 2023)

  Asad Murva, Mallon Dermot, Werring David
• CAPS (23 November, 2023)

  Bansal Dhruv, Peukert Thomas
• Cystic medial degeneration – a rare intracranial vasculopathy (23 November, 2023)

  Durcan Rob, Fullam Sarah, Farrell Michael, McGuigan Christopher
• Intensive blood pressure management in atraumatic intracranial haemorrhage: a quality improvement project (23 November, 2023)

  Gordon Alex, Board Christopher, Sterry Jennifer, Dawson Erin, Patha Rasa Valiimalar, Harris Helen
• Impact of Covid-19 pandemic on consensus decisions, adherence-to-advice and time-to-intervention following a neurovascular multidisciplinary meeting (23 November, 2023)

  Offiah Chika, Tierney Sean, Kemple Orla, Egan Bridget, Collins Rónán, Ryan Dan, McCarthy Allan, Smith Deirdre, Walsh John, McCabe Dominick
• Ischaemic stroke and arteriovenous thromboses secondary to anabolic steroid use and MTHFR 667 homozygous mutation (28 November, 2023)

  Rees Abigail, Chen Jian, Coughlan Charles, Goodison William, Chandratheva Arvind
• Conus medullaris infarction as a mimic of cauda equina syndrome (28 November, 2023)

  Richard Georgia, Leneghan Caoimhe, Liddy Anne Marie, Looby Seamus, McGovern Eavan
• Spinal dural arteriovenous fistula – a clinical chameleon (28 November, 2023)

  Tallon Eva, Connolly Sean, Kinsella Justin, McGuigan Christopher
• When the biopsy result is unexpected: a case of cerebral amyloid angiopathy-related inflammation (28 November, 2023)

  Todd Rachel, Herron Brian, Craig John, Flynn Peter, McVerry Ferghal
• The value of tibial F wave studies in peripheral nerve hyperexcitability syndromes (28 November, 2023)

  Gilligan Michael, Tubridy Niall, Connolly Sean
• The queen square neuromuscular MRI protocol: a responsive outcome measure in CMTX1, CMT1B and CMT2A (28 November, 2023)

  Doherty Carolynne, Morrow Jasper, Howard Paige, Zuccarino Riccardo, Wastling Stephen, Pipis Menelaos, Zafeiropoulos Nick, Stephens Katherine, Grider Tiffany
• Not so lethal congenital contractures: two adult cases of Lethal Congenital Contracture Syndrome Type 11 (28 November, 2023)

  Dolan Emma, Friel Oisin, Mullane Gerard, Kehoe Ciara, Mulkerrin Grainne, O’Rourke James, Whelehan Anna, Smyth Shane, Lefter Stela, McGovern Eavan
• Mycophenolate facilitates IVIG dose reduction in CIDP with improvement in clinical outcomes measures (28 November, 2023)

  Elsaddig Amar, Japzon Nicole, Miah Shamim, Carr Aisling, Lunn Michael
• Distal hereditary motor neuropathy in association with OTX2-related disorder (28 November, 2023)

  Field Robert, McHugh John, Costigan Donal, Gibney James, Murphy Sinéad
• The sum of its parts: emphasising the importance of PHYsical signs (28 November, 2023)

  Gandhi Sacha, Gall Claire, Davidson Amy
• A unique patient with DNM2 related peripheral neuropathy with myopathy (28 November, 2023)

  Haddad Saif, Skorupinska Mariola, Rossor Alex, Laura Matilde, Blake Julian, Lunn Michael, Reilly Mary
• Sensorimotor neuropathy with conduction block: broadening the phenotype associated with PIGG-related disease (28 November, 2023)

  O’Connor Antoinette, McHugh John, Murphy Sinead
• Validating MRI biomarkers for clinical trials in CMT1A using automated segmentation (28 November, 2023)

  O’Donnell Luke, Morrow Jasper, Pipis Menelaos, Thornton John, Wastling Stephen, McDowell Amy, Record Christopher, Study Group The ACT-CMT, Rossor Alexander, Reilly Mary
• Diffuse intraneural perineurioma presenting as bilateral brachial plexopathy (28 November, 2023)

  Record Christopher, Sivasathiaseelan Harri, Blake Julian, Gosal David, Lavin Tim, Jaunmuktane Zane, Brandner Sebastian, Lunn Michael, Reilly Mary
• A case of colostomy in acute peripheral neuropathy (28 November, 2023)

  Talaei Maryam, Johnston Janet Ann
• Development of a DGH nurse-led lumbar puncture clinic (28 November, 2023)

  Whisker Emily, Abdel-Aziz Khaled
• IIH in a DGH: reflections on 4 years of experience of a joint neuro-ophthalmology clinic (23 November, 2023)

  Fawcett Joanna, Hardwick Marc, Lewis Anna, Giffin Nicola
• Enhanced neurotrauma services: Physician input into traumatic brain injury care (23 November, 2023)

  Jenkins Damian, Harris Callum, Okamura Kumi, Stephens Lucie
• A comprehensive literature search of digital health technology use in neurological conditions and neurodegenerative diseases (23 November, 2023)

  Spreadbury John, Young Alexandra, Kipps Christopher
• Evaluating the use of a hospital-based online patient portal amongst people with long-term neurological conditions (23 November, 2023)

  Fearn Sarah, Spreadbury John, Chappell Rachel, Kipps Christopher
• Exploring the value components of a neurology outpatient appointment: a patient and carer perspective (23 November, 2023)

  Fearn Sarah, Kipps Christopher
• Neurology undergraduate medical education: a scoping review (23 November, 2023)

  McElligott Liah, Murphy Paul, Ardilouze Amelie, Moloney John, ElSheikhId Abubakr, Healy Caoimhe, Leahy Harriet, Babatunde Kehinde, Byrne Susan, McGovern Eavan
• Acute neurological admissions in Northern Ireland: amount, hospital type and admission specialty using GIRFT methodology (28 November, 2023)

  McVerry Ferghal, Hunt Stephen, Looney Dean, McAllister Karen, Heaney Eimhear, Pattison Sally, Jakobsen Peter, Hughes Stella, Craig John
• Developing the neurosciences patient-led involvement strategy in South West London (28 November, 2023)

  Ballard-Ridley Scott, Croll Emma, Murray Sarah, Williams Nicola, Nirmalananthan Niranjanan, Jones Fiona
• Croydon neurology: comparing non-attendance (DNA) rates in remote versus face-to-face outpatient clinic appointments (28 November, 2023)

  Manzur Hassan, Nitkunan Arani
• Croydon neurology: outpatient diagnostic coding is vital to address population neurological health needs (23 November, 2023)

  Nitkunan Arani, Collis Dominick, Harivardhan Keshav, Schon Fred
• Integrating palliative medicine into neurology: description of a novel fellowship in neuropalliative care (23 November, 2023)

  O’Shea Noreen, Higgins Stephen, O’Dowd Sean
• Plasma exchange via Hotel pathway is safe and provides better patient experi- ence at reduced cost (23 November, 2023)

  Takova Aneliya, McDonald Jenny, Wilson Eleanor, Spillane Jennifer
• Regional variations in the pharmacological management of narcolepsy in secondary care (23 November, 2023)

  van Someren Fred, Sun Fiona, Wiedemann Milan, Mackenna Brian, Eriksson Sofia, Strongman Helen
• Introducing a neuro-intensive care rotation for neurology trainees at a tertiary neurosciences centre (23 November, 2023)

  Hart Thomas, Crowe Andrew, Zhang Weijia